Skip to main content

Month: May 2025

Rogers Sugar Delivers Solid Second Quarter Results, with Record Performance from Maple Segment

VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Company”, “Rogers”, “RSI” or “our,” “we”, “us”) (TSX: RSI) today reported results for the second quarter and first six months of fiscal 2025. Consolidated adjusted EBITDA for the quarter amounted to $34.7 million, driven by strong performance in the Company’s Maple and Sugar segments. “We are pleased to share the strong and consistent results delivered by both our Sugar and Maple segments this quarter, driven by steady underlying demand for our sweeteners,” said Mike Walton, President and Chief Executive Officer of Rogers and Lantic Inc. “While we continue to focus on meeting the needs of our customers, we are closely monitoring the current uncertainty related to the trade situation between Canada and the United States, and we are engaging with...

Continue reading

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $369 million Over 6,000 patients treated to date Initiated CARVYKTI® clinical production at the Tech Lane facility Received positive CHMP opinion to add statistically significant improvement in overall survival from CARTITUDE-4 study to CARVYKTI® label Australia’s TGA approved CARVYKTI® in second-line plus settings for multiple myeloma patients Cash and cash equivalents, and time deposits of $1.0 billion, as of March 31, 2025, which Legend Biotech believes will provide financial runway into the second quarter of 2026SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2025 unaudited financial results and key corporate highlights. “CARVYKTI,...

Continue reading

Broadwind Announces First Quarter 2025 Results

CICERO, Ill., May 13, 2025 (GLOBE NEWSWIRE) —  Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results for the first quarter 2025. FIRST QUARTER 2025 RESULTSTotal revenue of $36.8 million Net loss of ($0.4) million, or ($0.02) per diluted share Total non-GAAP adjusted EBITDA of $2.4 million, or 6.4% of total revenue Ratio of net debt to trailing twelve-month non-GAAP adjusted EBITDA of 1.4x as of March 31, 2025 Total orders of $30.5 million, increased +5% y/y, as of March 31, 2025 Reiterating full-year 2025 revenue and Adjusted EBITDA guidanceBroadwind reported a net loss of ($0.4) million, or ($0.02) per diluted share in the first quarter 2025, compared to net income of $1.5 million, or $0.07 per diluted share,...

Continue reading

G2 Drills 76m @ 1.5 g/t Au and 3m @ 12.5 g/t Au in Scout Drilling at Peters Mine, Guyana

TORONTO, May 13, 2025 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased to announce diamond drilling results returning significant widths of near surface gold mineralisation in the initial first pass drilling program at the 8,358-acre Peters Mine Property, Guyana. The Peters Mine Property is part of a regional portfolio of gold properties in the historic Oko-Aremu-Peters Mine district, Guyana. The project lies approximately 35 km southwest of the Company’s flagship OKO property which hosts mineral resources of 1.5 million ounces of gold Indicated and 1.6 million ounces of gold Inferred (see press release dated March 10, 2025).   FIGURE 1 – Country MapHistory of the Property The Peters Mine was discovered in 1902 and subsequently developed as an underground mine, becoming operational...

Continue reading

Algernon to Acquire NoBrainer Imaging Centers, Inc. – Plans to Establish Alzheimer’s Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology

First Clinic Targeted to Open Q4, 2025 in the U.S. VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has entered into share exchange agreements to acquire 100% of the issued and outstanding shares of NoBrainer Imaging Centers, Inc. (“NIC”) (the “Transaction”). The Transaction moves Algernon into the Alzheimer’s Disease (“AD”) diagnostic and treatment market, expanding on the Company’s neurological research programs, and provides Algernon exclusive master franchise and licensing rights to open AD screening, diagnostic, and treatment centers across Canada and in multiple U.S. markets. Algernon plans to both establish company-owned...

Continue reading

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. First Quarter 2025 and Recent Business Highlights Nuwellis continued to advance its strategic priorities during the first quarter, delivering growth in customer categories and strengthening the foundation for broader adoption of Aquadex therapy. Higher CMS reimbursement, strong pediatric performance, and disciplined expense management position the company to capitalize on both inpatient growth and emerging outpatient opportunities in 2025.Revenue of $1.9 million, a 3% increase over the prior-year quarter. 4% growth in consumables utilization...

Continue reading

Form 8.3 – [GLOBALDATA PLC – 12 05 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GLOBALDATA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Interim report of Copenhagen Airports A/S (CPH) for the period 1 January – 31 March 2025

The Board of Directors has today approved the interim report for the period 1 January – 31 March 2025.COPENHAGEN AIRPORTS A/S P.O. Box 74 Lufthavnsboulevarden 6 DK-2770 KastrupContact: Rasmus Lund CFOTelephone: +45 3231 3231 E-mail: cphpresse@cph.dk www.cph.dk CVR nr. 14 70 72 04AttachmentQ1 2025 Report of Copenhagen Airports

Continue reading

Sotherly Hotels Inc. Reports Financial Results for the First Quarter Ended March 31, 2025

WILLIAMSBURG, Va., May 13, 2025 (GLOBE NEWSWIRE) — Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a “REIT”), today reported its consolidated results for the first quarter ended March 31, 2025. The Company’s results include the following*:  Three Months Ended    March 31, 2025     March 31, 2024         ($ in thousands except per share data)  Total revenues $ 48,312     $ 46,548  Net income   4,734       1,323  Net income (loss) attributable to common stockholders   2,691       (659 )           EBITDA   15,032       10,785  Hotel EBITDA   12,921       12,360             FFO attributable to common stockholders and unitholders   3,769       3,961  Adjusted FFO attributable to common stockholders and...

Continue reading

Endeavour Silver Announces Q1 2025 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today

VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) announces its financial and operating results for the three months ended March 31, 2025. All dollar amounts are in US dollars ($). “We’re pleased to report another strong quarter, with production tracking well against plan,” said Dan Dickson, Chief Executive Officer. “Our revenue performance was bolstered by higher realized prices, highlighting the strength of our portfolio. We continue to generate solid mine operating cash flow, underpinned by disciplined cost control and a relentless focus on operational excellence. With robust liquidity, the addition of the Kolpa project, and Terronera coming online soon, we are well positioned to drive sustainable growth and deliver long-term value for our...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.